A Randomized, Parallel Group, Double-masked, Active-controlled Phase 1/2 Clinical Trial to Evaluate the Efficacy and Safety of Dexamethasone Sodium Phosphate Visulex System for the Treatment of Non-infectious Anterior Uveitis

Trial Profile

A Randomized, Parallel Group, Double-masked, Active-controlled Phase 1/2 Clinical Trial to Evaluate the Efficacy and Safety of Dexamethasone Sodium Phosphate Visulex System for the Treatment of Non-infectious Anterior Uveitis

Completed
Phase of Trial: Phase I/II

Latest Information Update: 09 Mar 2018

At a glance

  • Drugs Dexamethasone (Primary) ; Prednisolone acetate
  • Indications Anterior uveitis
  • Focus Therapeutic Use
  • Sponsors Aciont
  • Most Recent Events

    • 09 Mar 2018 According to an Aciont media release, this study was supported by two phase 2 NEI SBIRs, reference by Grant R44EY014772.
    • 09 Mar 2018 According to an Aciont media release, clinical data from this trial will presented at the Association for Research in Vision and Ophthalmology (ARVO) 2018 annual meeting (April 29-May 3) in Honolulu, HI.
    • 25 Apr 2017 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top